ALLMedicine™ Urticaria Center
Research & Reviews 1,926 results
https://doi.org/10.1111/dth.15589
Dermatologic Therapy; Coşansu NC, Kara RÖ et. al.
May 19th, 2022 - Omalizumab has high treatment efficacy in patients with chronic spontaneous urticaria (CSU) who do not respond to high doses of antihistamines. Systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) were described...
https://www.mdedge.com/dermatology/article/254723/aesthetic-dermatology/benzophenone-safe-skin-care-part-1-risks-humans
Leslie S. Baumann, MD
May 18th, 2022 - Benzophenones are a family of compounds that include dixoxybenzone, sulisobenzone, and benzophenone-3, or oxybenzone. These benzophenones are found in various skin care and personal care products, including body washes, exfoliants, fragrances, liq.
https://clinicaltrials.gov/ct2/show/NCT03770273
May 13th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...
https://clinicaltrials.gov/ct2/show/NCT03749148
May 13th, 2022 - Treatment with Dupilumab has been shown to reduce clinically significant exacerbations and to improve skin symptom control as well as quality of life in moderate to severe atopic dermatitis patients and in moderate to severe asthma patients. It ha...
https://clinicaltrials.gov/ct2/show/NCT05298215
May 13th, 2022 - This is a phase II, double-blind, randomized, parallel group, placebo-controlled study to evaluate the pharmacodynamics, pharmacokinetics, efficacy, and safety of 2-dose UB-221 IV infusion as an add-on therapy in patients with chronic spontaneous ...
Guidelines 6 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.
Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.
Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.
Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...
https://doi.org/10.1111/j.1524-4725.2010.01495.x
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F
Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...
https://doi.org/10.1111/j.1398-9995.2009.02179.x
Allergy Zuberbier T, Asero R et. al.
Sep 24th, 2009 - This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: Management of urticaria. Allergy, 2009; 6...
Drugs 912 results see all →
Clinicaltrials.gov 73 results
https://clinicaltrials.gov/ct2/show/NCT03770273
May 13th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...
https://clinicaltrials.gov/ct2/show/NCT03749148
May 13th, 2022 - Treatment with Dupilumab has been shown to reduce clinically significant exacerbations and to improve skin symptom control as well as quality of life in moderate to severe atopic dermatitis patients and in moderate to severe asthma patients. It ha...
https://clinicaltrials.gov/ct2/show/NCT05373355
May 13th, 2022 - Successfully screened subjects will be randomized in a ratio of 1:1:1. After a 4-week screening period (day -28-0), subjects will be randomly assigned to treatment for 12 weeks. Clinical Urticaria Activity Score (UAS), dermatological Quality of ...
https://clinicaltrials.gov/ct2/show/NCT05129423
May 13th, 2022 - This pilot and dose-ranging study will evaluate the efficacy, safety, and pharmacokinetics of MTPS9579A compared with placebo in participants with chronic spontaneous urticaria (CSU) refractory to antihistamines. This study comprises two parts. In...
https://clinicaltrials.gov/ct2/show/NCT05298215
May 13th, 2022 - This is a phase II, double-blind, randomized, parallel group, placebo-controlled study to evaluate the pharmacodynamics, pharmacokinetics, efficacy, and safety of 2-dose UB-221 IV infusion as an add-on therapy in patients with chronic spontaneous ...
News 278 results
https://www.mdedge.com/dermatology/article/254723/aesthetic-dermatology/benzophenone-safe-skin-care-part-1-risks-humans
Leslie S. Baumann, MD
May 18th, 2022 - Benzophenones are a family of compounds that include dixoxybenzone, sulisobenzone, and benzophenone-3, or oxybenzone. These benzophenones are found in various skin care and personal care products, including body washes, exfoliants, fragrances, liq.
https://www.medscape.com/viewarticle/973382
May 4th, 2022 - A newly developed rating scale called the Cold Urticaria Activity Score (ColdUAS) can help patients with cold urticaria (ColdU) monitor their signs, symptoms, exposure to cold, and avoidance of cold by answering four simple questions, according to...
https://www.mdedge.com/familymedicine/article/253770/dermatology/case-cold-purple-toes
MDedge Family Medicine;
Apr 14th, 2022 - A punch-biopsy was performed on the left second toe where the erythema was the most intense. It demonstrated classic findings for pernio: superficial and deep perivascular lymphocytic inflammation and papillary dermal edema on the acral surface.
https://www.medscape.com/viewarticle/971747
Apr 7th, 2022 - A recently published set of treatment flow diagrams uses simplified diagnosis and management pathways to help primary care providers (PCPs) in Europe, the United States, and elsewhere treat patients with allergies. Most patients with allergy probl...
https://www.medscape.com/viewarticle/971251
Mar 31st, 2022 - Guidelines on the management of chronic urticaria were first published in November 2021 by the British Association of Dermatologists (BAD) in the British Journal of Dermatology.[1] Selected recommendations are outlined below. All Types of Chronic ...